Genetics may determine link between aspirin, colon cancer risk
the ONA take:
According to a new study published in the Journal of the American Medical Association (JAMA), researchers have found that a person's individual genetics may determine if a person will have a reduced risk of colon cancer from taking aspirin.
The association between taking aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) and colorectal cancer prevention is well known, but it is not understood why some people benefit from the agents and some do not.
Therefore, researchers from four countries sought to investigate whether there is an association between certain DNA variations and the protection that aspirin confers.
For the study, researchers analyzed the data of over 17,000 people from ten large studies. They identified 8,624 people who developed colorectal cancer and 8,553 people who did not.
Results showed that there was DNA evidence that 1 in 25 people do not benefit from aspirin. Researchers found that those people may actually have an increased risk of developing colorectal cancer if they take aspirin.
A person's individual genetics may determine if a person will have a reduced risk of colon cancer from taking aspirin.
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Study Identifies Factors Associated With Infection-related Complications in ALL
- Immune Checkpoint-Related Neurotoxicity May Be More Common During Combination Treatment
- New Recommendations for Secondary Prevention of Cervical Cancer
- Nonadherence to Posttreatment Imaging Follow-up Common Among Breast Cancer Survivors
- HIIT Improves Cardiorespiratory Fitness in Patients With Resectable NSCLC
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|